EDMONTON, Aug. 11 /CNW/ - (ISA:TSX): Isotechnika Inc. today announced two principal investigators from the Company’s recently completed Phase 2b kidney transplant (PROMISE) trial have been selected to make oral presentations at the 22nd International Congress of the Transplantation Society Conference in Sydney, Australia.
